Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity

Lana L. Jackson, Zane Wade, Richard B. Hessler, Rafik A Abdelsayed, Jeremy B. Rogers, Christine G. Gourin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

INTRODUCTION: Decreased expression of syndecan-1 has been reported in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity and appears to correlate with decreasing histological differentiation and poor clinical outcome. Assays of syndecan-1 expression to date have utilized manual microscopic analysis with qualitative grading of immunohistochemical staining intensity, which may introduce observer bias. We evaluated syndecan-1 expression in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity, using a novel automated cellular imaging system that incorporates both staining intensity as well as the percentage of positively stained cells to yield a quantitative value for syndecan-1 expression. MATERIALS AND METHODS: We performed a quantitative immunohistochemical analysis of syndecan-1 expression using an automated cellular image analysis system. We analyzed specimens from cases of mild dysplasia (N = 55), moderate dysplasia (N = 38), severe dysplasia (N = 25), carcinoma in situ (CIS) (N = 43), and SCCA of the oral cavity (N = 45), using normal mucosal epithelium (N = 21) as a positive control. The SCCA specimens were further subdivided by degree of differentiation. We retrospectively reviewed patient charts to identify tumor stage at diagnosis, recurrence, and disease-specific survival. RESULTS: Syndecan-1 expression was significantly greater in normal controls than in specimens of mild, moderate, or severe dysplasia, CIS, or invasive SCCA (P < .05). Syndecan-1 expression did not differ significantly among specimens of mild, moderate, or severe dysplasia, CIS or SCCA. There was no significant difference in syndecan-1 expression between specimens from patients with no evidence of disease at 3 years follow-up and patients with local, regional, or distant recurrence. CONCLUSIONS: Syndecan-1 expression does not appear to be useful as a marker of differentiation or as a prognostic indicator in dysplasia and SCCA of the oral cavity. The search for a suitable and reliable marker of biological aggressiveness is ongoing.

Original languageEnglish (US)
Pages (from-to)868-871
Number of pages4
JournalLaryngoscope
Volume117
Issue number5
DOIs
StatePublished - May 1 2007

Fingerprint

Syndecan-1
Mouth
Squamous Cell Carcinoma
Carcinoma in Situ
Staining and Labeling
Recurrence
Observer Variation
Differentiation Antigens
Epithelium
Biomarkers

Keywords

  • Dysplasia
  • Head and neck cancer
  • Oral cavity
  • Squamous cell carcinoma (SCCA)
  • Syndecan-1

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity. / Jackson, Lana L.; Wade, Zane; Hessler, Richard B.; Abdelsayed, Rafik A; Rogers, Jeremy B.; Gourin, Christine G.

In: Laryngoscope, Vol. 117, No. 5, 01.05.2007, p. 868-871.

Research output: Contribution to journalArticle

Jackson, Lana L. ; Wade, Zane ; Hessler, Richard B. ; Abdelsayed, Rafik A ; Rogers, Jeremy B. ; Gourin, Christine G. / Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity. In: Laryngoscope. 2007 ; Vol. 117, No. 5. pp. 868-871.
@article{48c56ef7607e42f8a9afcdde1fc33e8e,
title = "Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity",
abstract = "INTRODUCTION: Decreased expression of syndecan-1 has been reported in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity and appears to correlate with decreasing histological differentiation and poor clinical outcome. Assays of syndecan-1 expression to date have utilized manual microscopic analysis with qualitative grading of immunohistochemical staining intensity, which may introduce observer bias. We evaluated syndecan-1 expression in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity, using a novel automated cellular imaging system that incorporates both staining intensity as well as the percentage of positively stained cells to yield a quantitative value for syndecan-1 expression. MATERIALS AND METHODS: We performed a quantitative immunohistochemical analysis of syndecan-1 expression using an automated cellular image analysis system. We analyzed specimens from cases of mild dysplasia (N = 55), moderate dysplasia (N = 38), severe dysplasia (N = 25), carcinoma in situ (CIS) (N = 43), and SCCA of the oral cavity (N = 45), using normal mucosal epithelium (N = 21) as a positive control. The SCCA specimens were further subdivided by degree of differentiation. We retrospectively reviewed patient charts to identify tumor stage at diagnosis, recurrence, and disease-specific survival. RESULTS: Syndecan-1 expression was significantly greater in normal controls than in specimens of mild, moderate, or severe dysplasia, CIS, or invasive SCCA (P < .05). Syndecan-1 expression did not differ significantly among specimens of mild, moderate, or severe dysplasia, CIS or SCCA. There was no significant difference in syndecan-1 expression between specimens from patients with no evidence of disease at 3 years follow-up and patients with local, regional, or distant recurrence. CONCLUSIONS: Syndecan-1 expression does not appear to be useful as a marker of differentiation or as a prognostic indicator in dysplasia and SCCA of the oral cavity. The search for a suitable and reliable marker of biological aggressiveness is ongoing.",
keywords = "Dysplasia, Head and neck cancer, Oral cavity, Squamous cell carcinoma (SCCA), Syndecan-1",
author = "Jackson, {Lana L.} and Zane Wade and Hessler, {Richard B.} and Abdelsayed, {Rafik A} and Rogers, {Jeremy B.} and Gourin, {Christine G.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1097/MLG.0b013e318033c810",
language = "English (US)",
volume = "117",
pages = "868--871",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity

AU - Jackson, Lana L.

AU - Wade, Zane

AU - Hessler, Richard B.

AU - Abdelsayed, Rafik A

AU - Rogers, Jeremy B.

AU - Gourin, Christine G.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - INTRODUCTION: Decreased expression of syndecan-1 has been reported in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity and appears to correlate with decreasing histological differentiation and poor clinical outcome. Assays of syndecan-1 expression to date have utilized manual microscopic analysis with qualitative grading of immunohistochemical staining intensity, which may introduce observer bias. We evaluated syndecan-1 expression in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity, using a novel automated cellular imaging system that incorporates both staining intensity as well as the percentage of positively stained cells to yield a quantitative value for syndecan-1 expression. MATERIALS AND METHODS: We performed a quantitative immunohistochemical analysis of syndecan-1 expression using an automated cellular image analysis system. We analyzed specimens from cases of mild dysplasia (N = 55), moderate dysplasia (N = 38), severe dysplasia (N = 25), carcinoma in situ (CIS) (N = 43), and SCCA of the oral cavity (N = 45), using normal mucosal epithelium (N = 21) as a positive control. The SCCA specimens were further subdivided by degree of differentiation. We retrospectively reviewed patient charts to identify tumor stage at diagnosis, recurrence, and disease-specific survival. RESULTS: Syndecan-1 expression was significantly greater in normal controls than in specimens of mild, moderate, or severe dysplasia, CIS, or invasive SCCA (P < .05). Syndecan-1 expression did not differ significantly among specimens of mild, moderate, or severe dysplasia, CIS or SCCA. There was no significant difference in syndecan-1 expression between specimens from patients with no evidence of disease at 3 years follow-up and patients with local, regional, or distant recurrence. CONCLUSIONS: Syndecan-1 expression does not appear to be useful as a marker of differentiation or as a prognostic indicator in dysplasia and SCCA of the oral cavity. The search for a suitable and reliable marker of biological aggressiveness is ongoing.

AB - INTRODUCTION: Decreased expression of syndecan-1 has been reported in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity and appears to correlate with decreasing histological differentiation and poor clinical outcome. Assays of syndecan-1 expression to date have utilized manual microscopic analysis with qualitative grading of immunohistochemical staining intensity, which may introduce observer bias. We evaluated syndecan-1 expression in dysplasia and squamous cell carcinoma (SCCA) of the oral cavity, using a novel automated cellular imaging system that incorporates both staining intensity as well as the percentage of positively stained cells to yield a quantitative value for syndecan-1 expression. MATERIALS AND METHODS: We performed a quantitative immunohistochemical analysis of syndecan-1 expression using an automated cellular image analysis system. We analyzed specimens from cases of mild dysplasia (N = 55), moderate dysplasia (N = 38), severe dysplasia (N = 25), carcinoma in situ (CIS) (N = 43), and SCCA of the oral cavity (N = 45), using normal mucosal epithelium (N = 21) as a positive control. The SCCA specimens were further subdivided by degree of differentiation. We retrospectively reviewed patient charts to identify tumor stage at diagnosis, recurrence, and disease-specific survival. RESULTS: Syndecan-1 expression was significantly greater in normal controls than in specimens of mild, moderate, or severe dysplasia, CIS, or invasive SCCA (P < .05). Syndecan-1 expression did not differ significantly among specimens of mild, moderate, or severe dysplasia, CIS or SCCA. There was no significant difference in syndecan-1 expression between specimens from patients with no evidence of disease at 3 years follow-up and patients with local, regional, or distant recurrence. CONCLUSIONS: Syndecan-1 expression does not appear to be useful as a marker of differentiation or as a prognostic indicator in dysplasia and SCCA of the oral cavity. The search for a suitable and reliable marker of biological aggressiveness is ongoing.

KW - Dysplasia

KW - Head and neck cancer

KW - Oral cavity

KW - Squamous cell carcinoma (SCCA)

KW - Syndecan-1

UR - http://www.scopus.com/inward/record.url?scp=34247844457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247844457&partnerID=8YFLogxK

U2 - 10.1097/MLG.0b013e318033c810

DO - 10.1097/MLG.0b013e318033c810

M3 - Article

C2 - 17473685

AN - SCOPUS:34247844457

VL - 117

SP - 868

EP - 871

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 5

ER -